Andreas Gerber
Director de Operaciones en APEIRON Biologics AG .
Cargos activos de Andreas Gerber
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Director de Operaciones | 01/06/2021 | - |
Historial de carrera de Andreas Gerber
Formación de Andreas Gerber.
| University of Basel | Doctorate Degree |
| University of St. Gallen | Masters Business Admin |
Estadísticas
Internacional
| Suiza | 3 |
| Austria | 2 |
Operativa
| Chief Operating Officer | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Bolsa de valores
- Insiders
- Andreas Gerber
- Experiencia
